• 제목/요약/키워드: CARBO

검색결과 87건 처리시간 0.019초

CarboMEdics 기계판막을 이용한 심장판막 치환술의 임상 연구 (Clinical Study of Prosthetic Heart Valve Replacement with CarboMedics.)

  • 장원기;구자홍;조중구;김공수
    • Journal of Chest Surgery
    • /
    • 제33권1호
    • /
    • pp.45-50
    • /
    • 2000
  • Background: The CarboMedics prosthetic heart valve was produced in an attempt to improve the existing valve designs and was especially concerned with easily the implantation and further reduction of turbulence. Precise positioning of the valve in situ was achieved by the abilityof the valve to rotate relative to the sewing ring. Improved monitoring is possible due to increased radiopacity and the dacron sewing ring is coated with carbon to reduce pannus overgrowth. The leaflets have an opening angle of 78 degrees that apparently allows a rapid synchronous closure The aim of this study was to analyze the clinical performance of the CarboMedics valve prostheses(45 mitral 13 aortic and 7 double aortic-mitral valve replacement) were implanted in 65 patients(mean age 48.75$\pm$9.74 years) Result: The operative mortality was 3.1%(2/65) causes of death were low cardiac output syndrome. Total follow up was 1831 patient-months and mean follow up was 29.06$\pm$10.97 months/patient. No structural failure hemorrhage valve thrombosis and late death have been observed. Embolism occurred at a rate of 0.65%/Patient-year. Actuarial survival and thrombo-mbolism free rate at 36 months were 96.9% and 98.4% respectively. Consclusions: The CarboMedics valve stands for low valve related complicatons.

  • PDF

CarboMedics 판막의 10년 임상 성적 (Ten-year Clinical Experience with CarboMedics Valve)

  • 김근직;이응배;조준용;전상훈;장봉현;이종태;김규태
    • Journal of Chest Surgery
    • /
    • 제33권8호
    • /
    • pp.643-647
    • /
    • 2000
  • From March 1988 to June 1994, 275 CarboMedics cardiac valve prostheses(199 mitral, 70 aortic and 3 tricuspid) were implanted in 226 consecutive patients(mean age 39 years, male/female 90/136) by one surgical team operating on adult cardiac patients at Kyungpook University Hospital. Total follow up represented 16,848 patient-months(mean 76 months) and follow up rate was 96%. One hundred and forty-nine patients(66%) wer in NYHA functional class III or IV preoperatively, and 204 patients(99.5%) were in class I or II postoperatively. Early mortality was 4.9% and late death was 9.3%. The actuarial survival at 81 months was 86.l2$\pm$3.1%. The linearized incidence of valve-related death, prosthetic valve thrombosis, anticoagulation-related hemorrhage, non-structural dysfunction and reoperation were 0.71%, 0.43%, 0.07%, 0.21%, and 0.14% respectively. The 81-month rate of freedom from all valve related complications and deaths including hospital mortality was 88.1$\pm$2.5%. Thee facts suggest that the CarboMedics cardiac valve has excellent result, low incidence of valve-related complications and no structureal deterioration.

  • PDF

CarboMedics 기계판막의 임상경험 (Mid term experience with CarboMedics Medical Valve)

  • 김기출
    • Journal of Chest Surgery
    • /
    • 제26권10호
    • /
    • pp.753-760
    • /
    • 1993
  • The CarboMedics valve is a bileaflet prosthesis with excellent hemodynamic characteristics, but the long term surgical experience with this valve, its durability and its biocompatibility are unknown. During a 5 year period from october 1988 to July 1993, 748 prostheses [402 mitral, 261 aortic, 58 tricuspid, 27 pulmonic] were inserted in 552 patients [mean age 40.2 years]. The operative mortality was 6.6% [37/560, 13.2% in age group below 15 years and 5.7% above 15 years]. and the main causes of death were complex congenital malformation and left ventricular failure. Follow up was totaled 1182 patient- years and mean follow up was 28.3 months/patient. No structural failure has been observed. Hemorrhage was the most frequent valve related complication[1.78% / Patient-year]. Embolism occurred at a rate of 0.93% / Patient-year. There were 5 cases of valve thrombosis [0.42% / Patient-year, two fatal]. There occurred 11 late deaths[6 valve related] and 42 valve related complications. Actuarial survival at 5 years is 97.18 0.94% and actuarial complication free survival at 5 years is 89.07 1.54%. In summary, the CarboMedics valve stands for a durable valve substitute, with low valve related complications.

  • PDF

Preparation and Characterization of Enrofloxacin/Carbopol Complex in Aqueous Solution

  • Chun, Myung-Kwan;Choi, Hoo-Kyun
    • Archives of Pharmacal Research
    • /
    • 제27권6호
    • /
    • pp.670-675
    • /
    • 2004
  • Since the bitter taste of enrofloxacin apparently limit the patient compliance in the oral formulations of the antibacterial agent, the masking of the taste is essential for the improvement of the therapeutic effectiveness. Therefore, this study was carried out to examine the feasibility of taste masking of enrofloxacin by the retardation of its dissolution rate using the formation of complex between the drug and Carbopol. The complexation between Carbopol and enrofloxacin was confirmed by turbidity, UV spectrophotometry, wide angle X-ray diffraction, and differential scanning calorimetry. The enrofloxacin content in the complexes was 34% (Carbo-enrofloxacin complex I) and 57% (Carbo-enrofloxacin complex II) depending on the prepara-tion method. The dissolution rate of enrofloxacin from the complex increased as the pH was reduced. The dissolution rate of enrofloxacin from the Carbo-enrofloxacin complex I was significantly lower than that of the enrofloxacin powder. Therefore, these observations suggest that Carbo-enrofloxacin complex I can be used to mask the taste of enrofloxacin.

CarboMedics 판막의 6년 임상 성적 (Six-year Clinical Experience with CarboMedics Valve)

  • 구본원;허동명
    • Journal of Chest Surgery
    • /
    • 제29권9호
    • /
    • pp.971-976
    • /
    • 1996
  • 경북대학교 병원에서는 1988년 3월부터 1992년 10월까지 연속적인 166명의 환자(평균 나이 38세, 남녀 성비 66 대 100)에게 201개 (승모판 150개, 대동맥판 50개, 삼천판 1개)의 CarboMedics 인공 판막을 이식하였다. 전체 추적 기간은 6646환자-월(평균40개월)이었고, 추적율은 96%였다. 술전에 124명 이 뉴욕 심장병학회 기능 분류 )기와 4기에 속하였고, 술후에는 164명 (98.7 %)이 1기와 2기에 속하였다. 병원 사망은 4.2%였고, 만기 사망도 4.2%였다. 전체 집단에서 생존율의 중간값인 77개월까지의 생존율은 89.4 %였다. 판막 관련 사망, 인공 판막의 혈전, 항응고요법에 따른 출혈, 비구조적 기능 이상, 재수술등의 linearized incidence는 환자-연당 각각 0.72%, 0.18%, 0.18%, 0.18%, 0.36%였다. 77개월까지 판막 관련 사망이 없을 율은 94.9%, 인공 판막의 혈전이 없을 율은 99.4%, 항응고요법에 따른 출혈이 없을 율은 99.4%, 비구조적 기능 이상이 없을 율은 98.6%, 재수술이 필요하지 않을 율은 97.6%였다. 77개월까지 병원 사망을 포함한 모든 판막 관련 합병증과 사망이 없을 율은 90.9 %였다. 이상의 결과에서 CarboMedics 판막은 판막에 관련된 합병증이 적었고, 구조적 이상은 없어서 중단기 추적 조사 결과는 만족스러우며, 향후 장기 추적 검사를 요한다.

  • PDF

CarboMedics 기계판막의 단기 임상 성적 (Short-term Clinical Experience with CarboMedics Valve)

  • 우석정
    • Journal of Chest Surgery
    • /
    • 제25권6호
    • /
    • pp.661-671
    • /
    • 1992
  • From March 1988 to May 1991, 140 CarboMedics cardiac valve prostheses[75 mitral, 9 aortic and 28 double aortic-mitral] were implanted in 112 consecutive patients[mean age 36.7$\pm$11.6 years, male/female 48/76] by one surgical team operating on adult cardiac patients at Kyoungpook University Hospital Associated Surgical procedures were performed in 19 patients[16.9%]. Total follow up represented 2,345 patient-months[mean 22.4 months] and was 100% complete. Eighty-two patients[73%] were in NYHA functional class IIIor IV preoperatively and 102 patients [95%] were in class I or II postoperatively. Hospital[30 day] mortality was 4.4%, [3/75 mitral, 1/9 aortic, 1/28 double valve replacement] and late death was 1.7%. [1 /74 mitral, 1 /28 double valve replacement] The actuarial survival at 36 months was 94.0% after mitral, 80% after aortic, 92% after double valve replacement, and 93.2% for the total group. The linearized incidence of valve relater death, prosthetic valve thrombosis, anticoagulant related hemorrhage, and reoperation was 1.00%/pt-yr, 0.51%/pt/yr, 0.51%/pt-yr, and 0.51%/pt-yr respectively. The 36 month rates of freedom from valve replated death, thromboembolism, endocarditis, anti-coagulant related hemorrages, and reoperation were 98.75%, 99.08%, 100%, 99.04%, and 99.08% respectively. The 36 month rate of freedom from all valve related complications and deaths including hospital mortality was 90.2%. These fact suggest that the CarboMedics heart valve has excellent short-term result, low incidence of valve-related complications and valve dysfunction, and additional long term follow up study is necessary.

  • PDF

안정 동위원소를 이용한 육상 생태계의 물과 탄소의 순환 연구: 재검토 (Stable Isotope Studies for Constraining Water and Carbon Cycles in Terrestrial Ecosystems: A Review)

  • 이동호
    • 한국농림기상학회지
    • /
    • 제7권1호
    • /
    • pp.15-27
    • /
    • 2005
  • 육상생태계의 물/탄소 순환은 기후변화의 원인과 진행 과정 그리고 결과를 예측하는데 필수적인 기초 자료이다. CarboKorea와 HydroKorea 연구에서는 한반도의 대표적인 지형과 식생 유형에 적합한 물/탄소 순환 해석과 실황예보를 위한 기술개발을 목표로, 안정동위원소를 이용해 물/탄소 순환의 구성요소를 성인적으로 세분하는 연구를 수행하고 있다. 본 논문에서는 이러한 안정 동위원소 연구가 국내 생태계의 물과 탄소 순환연구에 적극적으로 활용될 수 있도록 하기 위해 그 이론적 배경과 광릉 소유역의 연구 사례를 소개하였다. 시간과 공간 규모의 확장을 가능케 하는 안정 동위원소 연구는 다양한 관련분야의 연구와 함께 한반도 육상생태계의 물/탄소 순환과정에 대한 보다 정량적인 해석을 가능하게 함으로써 기후변화와 관련하여 제기되고 있는 당면한 과학적, 사회경제적 요구에 부흥할 수 있는 과학적 기반을 구축하는데 기여할 것으로 기대된다.

카복시 테라피용 CO2 주입기의 설계 및 구현 (A Design and Implementation of CO2 Infuser for a Carbon Dioxide)

  • 박성곤;안찬진
    • 디지털콘텐츠학회 논문지
    • /
    • 제16권3호
    • /
    • pp.483-492
    • /
    • 2015
  • 최근에 비만을 치료하기 위한 요법 중에 카복시테라피 치료법이 있다. 이 방법은 지방이 과도하게 축적된 부위에 이산화탄소($CO_2$)를 주입하여 치료하는 방법으로 최근 각광받고 있다. 가스통에 담겨 있는 이산화탄소를 피부에 주입하려면 주입기가 필요하며, 건강을 위해 주입량을 정확히 조절할 수 있어야 한다. 본 논문에서는 국내에서 제작한 CARBO 3000이라는 이산화탄소 주입기의 유량주입 방법을 분석하고 단점을 파악한다. 유량 센서와 일정 유량이 출력되게 고정된 유속 조절기를 추가하여 주입된 정확한 유량을 보여줄 수 있는 모듈을 구현한다. 구현을 위해 하드웨어적으로는 CPU와 LCD, 유속 조절기를 선정하였으며 솔레노이드 밸브와 유량센서를 선정하고 구동을 시킬 수 있는 회로를 설계한다. 소프트웨어적으로는 주입된 이산화탄소의 양을 판별할 수 있는 GUI를 설계하고 유량을 제어할 수 있는 유량 제어 알고리즘을 설계한다.

CarboMedics 기계판막을 이용한 1,144예 판막치환술의 장기 성적 (Long-term Results after 1,144 CarboMedics Mechanical Valve Implantation)

  • 강창현;김경환;김기봉;안혁
    • Journal of Chest Surgery
    • /
    • 제37권7호
    • /
    • pp.559-569
    • /
    • 2004
  • CarboMedics 기계판막은 낮은 판막관련 합병증을 보인다고 보고되어 왔다. 이 논문의 목적은 CarboMedics기계판막 치환술 후 장기 임상성적을 분석하고자 하였다. 대상 및 방법: 1988년 8월부터 1999년 9월까지 850명의 환자를 대상으로 1144예의 CarboMedics 판막치환술이 이루어졌다(대동맥판막 치환군 179예, 승모판막 치환군 385예, 이중판막치환군 234예, 삼첨판막 치환군 52예). 환자들의 평균연령은 44.5 $\pm$ 12.5세였고 완전 추적관찰은 95.3%의 환자에서 이루어졌으며, 평균 추적관찰 기간은 7.9년이었다. 결과: 병원 사망률은 3.4%였으며, 환자군에 따라 분류하면 대동백판막군 1.7%, 승모판막군이 2.6%, 이중판막군 4.7%, 그리고 삼첨판막군 9.6%로서 삼첨판막군이 대동맥판막군이나 승모판막군보다 수술사망률이 높았다(p〈0.05). 대동맥판막군, 승모판막군, 이중판막군, 그리고 삼첨판막군의 10년 생존율은 각각 87.1 $\pm$ 2.6%, 88.9 $\pm$ 1.7%, 82.4 $\pm$ 2.9%, 그리고 77.5 $\pm$ 7.0% 였으며, 환자의 연령과 삼첨판막 치환술이 다변량분석에서 장기생존에 영향을 미치는 위험인자였다(p〈0.05). 대동맥판막군, 승모판막군, 이중판막군, 그리고 삼첨판막군의 10년 혈전색전증 회피율은 92.5 $\pm$ 2.3%, 94.2 $\pm$ 1.4%, 94.3 $\pm$ 1.7%, 그리고 97.8 $\pm$ 2.2%였으며, 10년 항응고제 연관 출혈 회피율은 92.5 $\pm$ 2.6%, 93.0 $\pm$ 1.5%, 96.7 $\pm$ 1.3%, 그리고 88.6 $\pm$ 5.5%였으며, 10년 판막혈전증 회피율은 99.4 $\pm$ 0.6%, 98.2 $\pm$ 0.8%, 99.2 $\pm$ 0.8%, 그리고 87.6 $\pm$ 0.5%로서 삼첨판막군이 다른 판막 치환군에 비해 의미 있게 높은 판막혈전증의 발생을 보였다(p 〈0.05). 결론: CarboMedics 기계판막을 이용한 판막치환술의 장기성적에서 만족할 만한 생존율과 낮은 판막관련 합병증을 확인할 수 있었다. 그러나 삼첨판막 치환술은 다른 위치의 판막치환술과 비교하여 높은 수술사망률과 판막혈전증의 빈도를 보였다.

Breeding Status of the Great cormorant Phalacrocorax Carbo (Phalacrocoracidae) at Paldang Lake in Korea

  • Jeong, Jinmun;Park, Jungho;Byun, Jinsoo;Song, Haengseop;Park, Heonwoo
    • Journal of Forest and Environmental Science
    • /
    • 제34권1호
    • /
    • pp.57-60
    • /
    • 2018
  • Great cormorant (Phalacrocorax carbo) have been growing on a large scale since they settled on Jokja Island in Lake Paldang in 2010. In 2017, 827 breeding nests were found in Jokja Island and the breeding success rate was $2.60{\pm}0.23$ per nest. Nestling tree did not show any specificity for the species and was severely damaged. As the nesting materials for cormorants, branches and leaves, which were easy to come by around the island, were used. Most of their prey were fish in Lake Paldang. The population the great cormorants showed high breeding success rate, indicating that Jokja Island was a good site for breeding. Thus, it shows that continuous research for them needs to be done.